Please assess the completion status of the following clinical trial:

Trial Title: Duration of Antibiotic Treatment of Erythema Migrans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* solitary erythema migrans in patients \> 15 years~Exclusion Criteria:~* a history of Lyme borreliosis in the past~* pregnancy or lactation~* immunocompromised status~* serious adverse event to doxycycline~* taking antibiotic with antiborrelial activity within 10 days~* multiple erythema migrans or extracutaneous manifestations of Lyme borreliosis

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- EM-10 days doxycycline (Type: ACTIVE_COMPARATOR): None
- EM-doxycycline 15 days (Type: ACTIVE_COMPARATOR): None
- controls (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).